PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance

PURPOSE: Programmed death-ligand 1 (PD-L1) has been widely used as a prognostic biomarker and an immunotherapeutic target in numerous cancers, but information on the clinical significance of its expression in endometrial serous carcinoma (ESC) is largely lacking. Here, we evaluate the predictive val...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Tao, Liu, Qin, Zhu, Yingfan, Zhang, Songfa, Peng, Qiaohua, Strickland, Amanda Louise, Zheng, Wenxin, Zhou, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684396/
https://www.ncbi.nlm.nih.gov/pubmed/34934360
http://dx.doi.org/10.2147/CMAR.S337271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684396/
https://www.ncbi.nlm.nih.gov/pubmed/34934360
http://dx.doi.org/10.2147/CMAR.S337271

Ejemplares similares